192 related articles for article (PubMed ID: 18312040)
1. Guideline implementation and patient-tailoring strategies to improve medication adherence for schizophrenia.
Hudson TJ; Owen RR; Thrush CR; Armitage TL; Thapa P
J Clin Psychiatry; 2008 Jan; 69(1):74-80. PubMed ID: 18312040
[TBL] [Abstract][Full Text] [Related]
2. A pilot study of barriers to medication adherence in schizophrenia.
Hudson TJ; Owen RR; Thrush CR; Han X; Pyne JM; Thapa P; Sullivan G
J Clin Psychiatry; 2004 Feb; 65(2):211-6. PubMed ID: 15003075
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of guideline implementation strategies on improving antipsychotic medication management for schizophrenia.
Owen RR; Hudson T; Thrush C; Thapa P; Armitage T; Landes RD
Med Care; 2008 Jul; 46(7):686-91. PubMed ID: 18580387
[TBL] [Abstract][Full Text] [Related]
4. Benchmarking the quality of schizophrenia pharmacotherapy: a comparison of the Department of Veterans Affairs and the private sector.
Leslie DL; Rosenheck RA
J Ment Health Policy Econ; 2003 Sep; 6(3):113-21. PubMed ID: 14646004
[TBL] [Abstract][Full Text] [Related]
5. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
6. Poor antipsychotic adherence among patients with schizophrenia: medication and patient factors.
Valenstein M; Blow FC; Copeland LA; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
Schizophr Bull; 2004; 30(2):255-64. PubMed ID: 15279044
[TBL] [Abstract][Full Text] [Related]
7. Treatment adherence and insight in schizophrenia.
Bitter I; Fehér L; Tényi T; Czobor P
Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
[TBL] [Abstract][Full Text] [Related]
8. A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.
Boardman G; McCann T; Kerr D
J Adv Nurs; 2014 Oct; 70(10):2293-302. PubMed ID: 24628395
[TBL] [Abstract][Full Text] [Related]
9. Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission.
Valenstein M; Copeland LA; Blow FC; McCarthy JF; Zeber JE; Gillon L; Bingham CR; Stavenger T
Med Care; 2002 Aug; 40(8):630-9. PubMed ID: 12187177
[TBL] [Abstract][Full Text] [Related]
10. Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia.
Shafrin J; Schwartz TT; Lakdawalla DN; Forma FM
J Manag Care Spec Pharm; 2016 Nov; 22(11):1285-1291. PubMed ID: 27783545
[TBL] [Abstract][Full Text] [Related]
11. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.
Gilmer TP; Dolder CR; Lacro JP; Folsom DP; Lindamer L; Garcia P; Jeste DV
Am J Psychiatry; 2004 Apr; 161(4):692-9. PubMed ID: 15056516
[TBL] [Abstract][Full Text] [Related]
12. Use of pharmacy data to assess quality of pharmacotherapy for schizophrenia in a national health care system: individual and facility predictors.
Leslie DL; Rosenheck RA
Med Care; 2001 Sep; 39(9):923-33. PubMed ID: 11502950
[TBL] [Abstract][Full Text] [Related]
13. Assertive community treatment in veterans affairs settings: impact on adherence to antipsychotic medication.
Valenstein M; McCarthy JF; Ganoczy D; Bowersox NW; Dixon LB; Miller R; Visnic S; Slade EP
Psychiatr Serv; 2013 May; 64(5):445-51, 451.e1. PubMed ID: 23412131
[TBL] [Abstract][Full Text] [Related]
14. The use of individually tailored environmental supports to improve medication adherence and outcomes in schizophrenia.
Velligan DI; Diamond PM; Mintz J; Maples N; Li X; Zeber J; Ereshefsky L; Lam YW; Castillo D; Miller AL
Schizophr Bull; 2008 May; 34(3):483-93. PubMed ID: 17932089
[TBL] [Abstract][Full Text] [Related]
15. A prospective evaluation of adherence to medication in first episode schizophrenia.
Kamali M; Kelly BD; Clarke M; Browne S; Gervin M; Kinsella A; Lane A; Larkin C; O'Callaghan E
Eur Psychiatry; 2006 Jan; 21(1):29-33. PubMed ID: 16460918
[TBL] [Abstract][Full Text] [Related]
16. The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia.
Kopelowicz A; Zarate R; Wallace CJ; Liberman RP; Lopez SR; Mintz J
Arch Gen Psychiatry; 2012 Mar; 69(3):265-73. PubMed ID: 22393219
[TBL] [Abstract][Full Text] [Related]
17. Agreement between patients with schizophrenia and providers on factors of antipsychotic medication adherence.
Pyne JM; McSweeney J; Kane HS; Harvey S; Bragg L; Fischer E
Psychiatr Serv; 2006 Aug; 57(8):1170-8. PubMed ID: 16870969
[TBL] [Abstract][Full Text] [Related]
18. [Predictors of medication non-adherence among a Moroccan sample of patients with schizophrenia: A cross sectional study].
El Ammouri A; Kisra H
Encephale; 2017 Dec; 43(6):522-527. PubMed ID: 27663045
[TBL] [Abstract][Full Text] [Related]
19. Effect of Community-Based Social Skills Training and Tai-Chi Exercise on Outcomes in Patients with Chronic Schizophrenia: A Randomized, One-Year Study.
Kang R; Wu Y; Li Z; Jiang J; Gao Q; Yu Y; Gao K; Yan Y; He Y
Psychopathology; 2016; 49(5):345-355. PubMed ID: 27584836
[TBL] [Abstract][Full Text] [Related]
20. Factors related to antipsychotic oversupply among Central Texas Veterans.
Yang M; Barner JC; Worchel J
Clin Ther; 2007 Jun; 29(6):1214-25. PubMed ID: 17692735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
